To investigate the safety and pharmacokinetics of SLV342

• Research type

  Research Study

• Full title

  A double-blind, randomised, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of SLV342 in healthy male subjects.

• IRAS ID

  40265

• Sponsor organisation

  Laboratoires Fournier SA, a company of Solvay Pharmaceuticals

• Eudract number

  2009-014245-88

• Research summary

  The import did not bring in any data, please check the applicants form to see if they filled in the Research Summary. If so please import the form again. This problem may have been caused by the an application form being imported before the research summary functionality was available. Please phone the helpdesk if you have any questions or require advice.

• REC name

  London - London Bridge Research Ethics Committee

• REC reference

  09/H0804/101

• Date of REC Opinion

  21 Jan 2010

• REC opinion

  Further Information Favourable Opinion